Cargando…
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis
Critical issues in prostate cancer (PC) are a. identification of molecular drivers of the highly aggressive neuroendocrine differentiation (NED) in adenocarcinoma, and b. early assessment of disease progression. The SRY (sex determining region Y)-box 2 gene, SOX2, is an essential embryonic stem cell...
Autores principales: | Russo, Marco Vincenzo, Esposito, Silvia, Tupone, Maria Grazia, Manzoli, Lamberto, Airoldi, Irma, Pompa, Paolo, Cindolo, Luca, Schips, Luigi, Sorrentino, Carlo, Di Carlo, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914291/ https://www.ncbi.nlm.nih.gov/pubmed/26540632 http://dx.doi.org/10.18632/oncotarget.6029 |
Ejemplares similares
-
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression
por: Esposito, Silvia, et al.
Publicado: (2015) -
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
por: Airoldi, Irma, et al.
Publicado: (2015) -
The antitumor potential of Interleukin-27 in prostate cancer
por: Di Carlo, Emma, et al.
Publicado: (2013) -
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes
por: Meldolesi, Elisa, et al.
Publicado: (2022) -
Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer
por: Wakatsuki, Masaru, et al.
Publicado: (2014)